Rhumbline Advisers X Biotech Inc. Put Options Transaction History
Rhumbline Advisers
- $103 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding XBIT
# of Institutions
47Shares Held
3.96MCall Options Held
6.3KPut Options Held
1.7K-
Israel Englander Millennium Management LLC | New York, Ny927KShares$5.48 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA895KShares$5.29 Million0.0% of portfolio
-
Black Rock Inc. New York, NY307KShares$1.81 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$1.47 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA195KShares$1.15 Million0.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $180M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...